Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium
Candidate cardiomyocyte (CM) mitogens such as those affecting the extracellular signal-regulated kinase (ERK) signaling pathway represent potential targets for functional heart regeneration. We explored whether activating ERK via a constitutively active mutant of B-raf proto-oncogene (BRAF), BRAF-V600E (caBRAF), can induce proproliferative effects in neonatal rat engineered cardiac tissues (ECTs). Sustained CM-specific caBRAF expression induced chronic ERK activation, substantial tissue growth, deficit in sarcomeres and contractile function, and tissue stiffening, all of which persisted for at least 4 weeks of culture. caBRAF-expressing CMs in ECTs exhibited broad transcriptomic changes, shift to glycolytic metabolism, loss of connexin-43, and a promigratory phenotype. Transient, doxycycline-controlled caBRAF expression revealed that the induction of CM cycling is rapid and precedes functional decline, and the effects are reversible only with short-lived ERK activation. Together, direct activation of the BRAF kinase is sufficient to modulate CM cycling and functional phenotype, offering mechanistic insights into roles of ERK signaling in the context of cardiac development and regeneration.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Science advances - 10(2024), 4 vom: 26. Jan., Seite eadh2598 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Strash, Nicholas [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 2.7.11.1 |
---|
Anmerkungen: |
Date Completed 26.01.2024 Date Revised 01.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1126/sciadv.adh2598 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367565218 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367565218 | ||
003 | DE-627 | ||
005 | 20240201232208.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240125s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1126/sciadv.adh2598 |2 doi | |
028 | 5 | 2 | |a pubmed24n1277.xml |
035 | |a (DE-627)NLM367565218 | ||
035 | |a (NLM)38266090 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Strash, Nicholas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.01.2024 | ||
500 | |a Date Revised 01.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Candidate cardiomyocyte (CM) mitogens such as those affecting the extracellular signal-regulated kinase (ERK) signaling pathway represent potential targets for functional heart regeneration. We explored whether activating ERK via a constitutively active mutant of B-raf proto-oncogene (BRAF), BRAF-V600E (caBRAF), can induce proproliferative effects in neonatal rat engineered cardiac tissues (ECTs). Sustained CM-specific caBRAF expression induced chronic ERK activation, substantial tissue growth, deficit in sarcomeres and contractile function, and tissue stiffening, all of which persisted for at least 4 weeks of culture. caBRAF-expressing CMs in ECTs exhibited broad transcriptomic changes, shift to glycolytic metabolism, loss of connexin-43, and a promigratory phenotype. Transient, doxycycline-controlled caBRAF expression revealed that the induction of CM cycling is rapid and precedes functional decline, and the effects are reversible only with short-lived ERK activation. Together, direct activation of the BRAF kinase is sufficient to modulate CM cycling and functional phenotype, offering mechanistic insights into roles of ERK signaling in the context of cardiac development and regeneration | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Proto-Oncogene Proteins B-raf |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a Extracellular Signal-Regulated MAP Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.24 |2 NLM | |
700 | 1 | |a DeLuca, Sophia |e verfasserin |4 aut | |
700 | 1 | |a Janer Carattini, Geovanni L |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yifan |e verfasserin |4 aut | |
700 | 1 | |a Wu, Tianyu |e verfasserin |4 aut | |
700 | 1 | |a Helfer, Abbigail |e verfasserin |4 aut | |
700 | 1 | |a Scherba, Jacob |e verfasserin |4 aut | |
700 | 1 | |a Wang, Isabella |e verfasserin |4 aut | |
700 | 1 | |a Jain, Mehul |e verfasserin |4 aut | |
700 | 1 | |a Naseri, Ramona |e verfasserin |4 aut | |
700 | 1 | |a Bursac, Nenad |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Science advances |d 2015 |g 10(2024), 4 vom: 26. Jan., Seite eadh2598 |w (DE-627)NLM247717614 |x 2375-2548 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2024 |g number:4 |g day:26 |g month:01 |g pages:eadh2598 |
856 | 4 | 0 | |u http://dx.doi.org/10.1126/sciadv.adh2598 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2024 |e 4 |b 26 |c 01 |h eadh2598 |